Aging, immunity, and tumor susceptibility

Immunology and Allergy Clinics of North America

Volumn 23, Issue 1, 2003, Pages 83-102

  Zhang, Huang Ge ^a,b   Grizzle, William E ^c  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGING; CANCER RISK; CANCER SUSCEPTIBILITY; DISEASE ASSOCIATION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TUMOR IMMUNITY;

AGE OF ONSET; AGED; AGING; ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, NATURAL; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0037325417     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8561(02)00085-1     Document Type: Review

References (44)

1. American Cancer Society. Cancer facts and figures. Atlanta (GA): American Cancer Society; 2002.
2. Cotran RS, Kumar V, Collins T. In: Robbins pathologic basis of disease, sixth edition. Philadelphia: WB Saunders; 1999.
3. DeVita Jr VT, Hellman S, Rosenberg SA. Cancer of the colon. In: DeVita Jr VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 6th edition. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 1216-71.
4. Cole P, Rodu B. Analytic epidemiology - cancer causes. In: DeVita Jr VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 6th edition. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 241-52.
5. Cole P, Rodu B. Descriptive epidemiology. Cancer statistics. In: DeVita Jr VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 6th edition. Philadelphia: Lippincott, Williams & Wilkins; 2001.
6. Mendelsohn J, Howley PM, Israel MA, Liotta LA. The molecular basis of cancer, 2nd edition. Philadelphia: WB Saunders; 2001.
7. Talley LI, Grizzle WE, Waterbor JW, et al. Hormone receptors and proliferation in breast carcinomas of equivalent histologic grades in pre- and postmenopausal women. Int J Cancer 2002;98(1):118-27.
8. Manne U, Weiss HL, Grizzle WE. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas. Clin Cancer Res 2000;6(10):4017-25.
9. Moore OS, Foote FW. The relatively favorable prognosis of medullary carcinoma of the breast. Cancer 1949;2:635-42.
10. Ridolfi RL, Rosen P, Port A, Kinne D, et al. Medullary carcinoma of the breast: a clinicopathologic study with 10 year follow-up. Cancer 1977;40:1365-85.
11. Wargotz ES, Silverberg SG. Medullary carcinoma of the breast: a clinicopathologic study with appraisal of current diagnostic criteria. Hum Pathol 1988;19(11):1340-6.
12. Rapin V, Contesso G, Mouriesse H, et al. Medullary breast carcinoma. A reevaluation of 95 cases of breast cancer with inflammatory stroma. Cancer 1988;61(12):2503-10
13. Lanza G, Gafa R, Matteuzzi M, et al. Medullary-type poorly differentiated adenocarcinoma of the large bowel: a distinct clinicopathologic entity characterized by microsatellite instability and improved survival. J Clin Oncol 1999;17(8):2429-38.
14. Ruschoff J, Dietmaier W, Luttges J, et al. Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol 1997;150(5):1815-25.
15. De Petris G, Lev R, Quirk DM, et al. Lymphoepithelioma-like carcinoma of the colon in a patient with hereditary nonpolyposis colorectal cancer. Arch Pathol Lab Med 1999;123(8):720-4.
16. McGovern VJ. Spontaneous regression of melanoma. Pathology 1975;7(2):91-9.
17. Bustamante R, Schmitt D, Pillet C, et al. Immunoglobulin-producing cells in the inflammatory infiltrates of cutaneous tumors. Immunocytologic identification in situ. J Invest Dermatol 1977;68(6):346-9.
18. Viac J, Bustamante R, Thivolet J. Characterization of mononuclear cells in the inflammatory infiltrates of cutaneous tumours. Br J Dermatol 1977;97(1):1-10.
19. Lynch HT, Frichot III BC, Fisher J, et al. Spontaneous regression of metastatic malignant melanoma in 2 sibs with xeroderma pigmentosum. J Med Genet 1978;15(5):357-62.
20. Samaha S, Tawfik O, Horvat R, et al. Lymphoepithelioma-like carcinoma of the colon: report of a case with histologic, immunohistochemical, and molecular studies for Epstein-Barr virus. Dis Colon Rectum 1998;41(7):925-8.
21. Wilson RE, Hager EB, Hampers CL, et al. Immunologic rejection of human cancer transplanted with a renal allograft. N Engl J Med 1968;278(9):479-83.
22. Gross L. Tentative guidelines referring to inoculation ofhomologous cancer extracts in man. Int J Cancer 1971;7(l):182-5.
23. Everson TC, Cole WH. Spontaneous regression of cancer. Preliminary Report. Ann Surg 1956;144(3):366-83.
24. Herr HW, Shipley WU, Bojarin DF. Cancer of the bladder. In: DeVita Jr VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 6th edition. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 1396-141.
25. Penn I. Sarcomas in organ allograft recipients. Transplantation 1995;60(12):1485-91.
26. Schultz TF, Bashoff CH, Weiss RA. HIV infection and neoplasia. Lancet Oncol 1996;348:587-91.
27. Mackall CL. T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review. Stem Cells 2000;18(1):10-8.
28. Rosenberg SA. Principles of cancer management. Biologic therapy. In: DeVita Jr VT, Hellman S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 6th edition. Philadelphia: Lippincott, Williams & Wilkins; 2001. p. 307-33.
29. Zbar B, Bernstein ID, Rapp HJ. Suppression of tumor growth at the site of infection with living bacillus Calmette-Guerin. J Natl Cancer Inst 1971;46(4):831-9.
30. Bar-Dayan Y, Aronson M, Small M. Thymic aging in ICR female mice is suspended by prolonged hydrocortisone exposure. Cell Tissue Res 1997;290(3):609-13.
31. Hameed MR, Coffman FD, Cohen S, et al. Differences in the pattern of proliferative response with age in thymocytes undergoing spontaneous and induced proliferation. Cell Immunol 1989;123(2):405-16.
32. Hsu HC, Mountz JD, Williams RW, et al, Age-related change in thymic T-cell development is associated with genetic loci on mouse chromosomes 1, 3, and 11. Mech Ageing Dev 2002; 123(8):1145-58.
33. Grizzle WE, Mountz JD, Yang PA, et al. BXD recombinant inbred mice represent anovel Tcell-mediated immune response tumor model. Int J Cancer 2002;101(3):270-9.
34. Horvath JA, Mostowski HS, Okumura K, et al. Pore-forming protein in individual cytotoxic T lymphocytes: the effect of senescence provides a probe for understanding the lytic mechanism. Eur J Immunol 1992;22(10):2649-54.
35. Mullbacher A, Waring P, Tha Hla R, et al. Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proc Natl Acad Sci USA 1999;96(24):13950-5.
36. Dennett NS, Barcia RN, McLeod JD. Age associated decline in CD25 and CD28 expression correlate with an increased susceptibility to CD95 mediated apoptosis in T cells. Exp Gerontol 2002;37(2-3):271-83.
37. Wedderbum LR, Patel A, Varsani H, et al. The developing human immune system: T-cell receptor repertoire of children and young adults shows a wide discrepancy in the frequency of persistent oligoclonal T-cell expansions. Immunology 2001;102(3):301-9.
38. Effros RB. Costimulatory mechanisms in the elderly. Vaccine 2000;18(16):1661-5.
39. Potestio M, Pawelec G, Di Lorenzo G, et al. Age-related changes in the expression of CD95 (APO1/FAS) on blood lymphocytes. Exp Gerontol 1999;34(5):659-73.
40. Pawelec G, Effros RB, Caruso C, et al. T cells and aging. Front Biosci 1999;4:D216-69.
41. Naquet P, MacDonald HR, Brekelmans P, et al. A novel T cell-activating molecule (THAM) highly expressed on CD4-CD8-murine thymocytes. J Immunol 1988;141(12):4101-9.
42. Vidan MT, Femandez-Gutierrez B, Hemandez-Garcia C, et al. Functional integrity ofthe CD28 co-stimulatory pathway in T lymphocytes from elderly subjects. Age Ageing 1999;28(2):221-7.
43. Vallejo AN, Bryl E, Klarskov K, et al. Molecular basis for the loss of CD28 expression in senescent T cells. J Biol Chem 2002;277:46940-9.
44. Al-Sarireh B, Eremin O. Tumour-associated macrophages (TAMS): disordered function, immune suppression and progressive tumour growth. J R Coll Surg Edinb 2000;45(1):1-16.